https://ecompliance.co.jp/what-compliance-really-means/2026-08-31T04:47:58+09:00https://ecompliance.co.jp/device-software-regulatory-requirements/2026-09-02T00:25:03+09:00https://ecompliance.co.jp/software-validation-in-device-firms/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/what-is-an-organization/2026-08-31T04:47:51+09:00https://ecompliance.co.jp/iso-9001-2/2026-08-31T04:47:51+09:00https://ecompliance.co.jp/review/2019-05-31T10:33:57+09:00https://ecompliance.co.jp/about-review-and-approval/2026-08-31T04:47:51+09:00https://ecompliance.co.jp/importance-of-supplier-control/2026-08-31T04:47:48+09:00https://ecompliance.co.jp/about-internal-audits/2026-08-31T04:47:51+09:00https://ecompliance.co.jp/audits-required-by-regulators/2026-08-31T04:47:51+09:00https://ecompliance.co.jp/about-self-inspection/2020-02-21T10:42:21+09:00https://ecompliance.co.jp/misconceptions-in-design-control/2019-07-23T10:46:24+09:00https://ecompliance.co.jp/design-and-development-plan/2026-08-31T04:48:03+09:00https://ecompliance.co.jp/fda-design-input-key-points/2026-08-31T04:48:03+09:00https://ecompliance.co.jp/fda-design-output-key-points/2026-08-31T04:48:01+09:00https://ecompliance.co.jp/fda-design-review-key-points/2019-06-02T10:51:27+09:00https://ecompliance.co.jp/what-is-design-validation/2026-08-31T04:47:49+09:00https://ecompliance.co.jp/what-is-design-transfer/2026-08-31T04:48:01+09:00https://ecompliance.co.jp/what-is-a-design-change/2026-08-31T04:47:48+09:00https://ecompliance.co.jp/device-history-file-dhf/2018-06-24T11:03:00+09:00https://ecompliance.co.jp/importance-of-device-design-control/2019-01-14T13:50:00+09:00https://ecompliance.co.jp/fda-process-design-key-points/2019-06-02T13:53:00+09:00https://ecompliance.co.jp/152-2/2026-08-31T04:48:02+09:00https://ecompliance.co.jp/key-points-of-the-pmd-act/2026-08-31T04:47:47+09:00https://ecompliance.co.jp/regulation-built-on-device-traits/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/what-is-qms-ordinance-japan/2026-09-02T00:43:46+09:00https://ecompliance.co.jp/medical-device-quality-regulations/2026-09-02T00:43:46+09:00https://ecompliance.co.jp/zero_risk/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/competence/2020-02-23T14:20:04+09:00https://ecompliance.co.jp/medical-device-regulatory-trends/2026-08-31T04:47:48+09:00https://ecompliance.co.jp/sekkei-kanri/2026-08-31T04:46:47+09:00https://ecompliance.co.jp/kobai-kanri/2026-08-31T04:38:06+09:00https://ecompliance.co.jp/capa-2/2026-08-31T04:38:03+09:00https://ecompliance.co.jp/fda-qmsr/2026-08-31T04:46:47+09:00https://ecompliance.co.jp/what-is-ce-marking-system/2020-02-24T15:39:15+09:00https://ecompliance.co.jp/mdr-application-date-extended/2026-08-31T04:47:46+09:00https://ecompliance.co.jp/what-is-mdr/2026-08-31T04:47:47+09:00https://ecompliance.co.jp/guidance-on-article-15-of-the-medical-device-regulation-mdr-and-in-vitro-diagnostic-device-regulation-ivdr-regarding-a-person-responsible-for-regulatory-complianceprrc/2026-08-31T04:47:47+09:00https://ecompliance.co.jp/what-is-mdsap/2018-08-09T09:51:51+09:00https://ecompliance.co.jp/iso-13485-2016-standard-overview/2026-08-31T04:47:52+09:00https://ecompliance.co.jp/what-is-usability/2026-08-31T04:47:59+09:00https://ecompliance.co.jp/human-factors-and-usability-guidance/2018-06-26T10:08:58+09:00https://ecompliance.co.jp/what-is-fda-qsr/2026-08-31T04:47:50+09:00https://ecompliance.co.jp/qsrvs134852016/2026-08-31T04:47:52+09:00https://ecompliance.co.jp/part-820-qsr-japanese/2019-02-20T10:17:00+09:00https://ecompliance.co.jp/stricter-510k-review-and-software/2026-08-31T04:47:59+09:00https://ecompliance.co.jp/guidance-for-the-content-of-premarket-submissions-for-software-contained/2026-08-31T04:47:51+09:00https://ecompliance.co.jp/refuse-to-accept-policy-for-510ks/2019-02-18T10:20:26+09:00https://ecompliance.co.jp/the-510k-program-evaluating-substantial-equivalence-in-premarket-notifications-510k/2026-08-31T04:47:51+09:00https://ecompliance.co.jp/21-cfr-part-801-labeling/2026-09-02T22:00:38+09:00https://ecompliance.co.jp/labeling/2021-07-07T09:15:00+09:00https://ecompliance.co.jp/21-cfr-part-803-mdr/2026-08-31T04:47:51+09:00https://ecompliance.co.jp/21cfr803-mdr-japanese/2019-02-18T11:18:00+09:00https://ecompliance.co.jp/21-cfr-part-806-correctionremoval/2026-08-31T04:47:50+09:00https://ecompliance.co.jp/21-cfr-part-809-ivd/2026-08-31T04:47:50+09:00https://ecompliance.co.jp/udi/2018-06-24T11:21:52+09:00https://ecompliance.co.jp/udi-rule-and-guidances-training-resources-and-dockets/2018-06-24T11:23:13+09:00https://ecompliance.co.jp/udi-basics/2018-06-24T11:23:57+09:00https://ecompliance.co.jp/guidance-for-industry-third-parties/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/guidance-for-industry-process-validation-general-principles-and-practices-2011-1/2026-08-31T04:47:59+09:00https://ecompliance.co.jp/electronic-source-documentation-jp/2019-02-26T11:34:00+09:00https://ecompliance.co.jp/what-matters-in-document-control/2026-08-31T04:48:03+09:00https://ecompliance.co.jp/fda-enforcement-statistics/2026-08-31T04:47:58+09:00https://ecompliance.co.jp/what-is-the-fdc-act/2026-08-31T04:48:02+09:00https://ecompliance.co.jp/what-is-the-cfr/2026-08-31T04:48:02+09:00https://ecompliance.co.jp/companies-that-reassure-inspectors/2019-01-17T13:08:00+09:00https://ecompliance.co.jp/how-to-research-fda-inspectors/2019-01-17T13:10:00+09:00https://ecompliance.co.jp/attending-an-fda-inspection/2026-08-31T04:47:58+09:00https://ecompliance.co.jp/why-a-back-room-is-needed/2026-08-31T04:47:58+09:00https://ecompliance.co.jp/avoiding-fda-inspection-findings/2026-08-31T04:47:58+09:00https://ecompliance.co.jp/guidance-on-delayed-refused-inspections/2018-06-25T13:44:00+09:00https://ecompliance.co.jp/evaluation-in-fda-inspections/2026-08-31T04:47:57+09:00https://ecompliance.co.jp/tips-for-fda-inspections/2026-08-31T04:47:57+09:00https://ecompliance.co.jp/quality-of-interpreters/2019-01-17T13:48:00+09:00https://ecompliance.co.jp/are-originals-required-in-inspections/2026-08-31T04:47:57+09:00https://ecompliance.co.jp/what-is-form-fda-483-2/2026-08-31T04:47:50+09:00https://ecompliance.co.jp/how-form-483-is-written/2026-09-02T00:43:46+09:00https://ecompliance.co.jp/what-is-form-fda-483/2026-08-31T04:47:50+09:00https://ecompliance.co.jp/qsit-capa-subsystem-preparation/2026-08-31T04:47:50+09:00https://ecompliance.co.jp/process-validation/2026-08-31T04:47:50+09:00https://ecompliance.co.jp/warning-letters-on-software/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/warning-letters-on-excel/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/three-elements-of-compliance/2026-08-31T04:47:50+09:00https://ecompliance.co.jp/building-an-fda-compliant-plm/2026-08-31T04:48:01+09:00https://ecompliance.co.jp/what-is-a-quality-event-system/2026-08-31T04:48:01+09:00https://ecompliance.co.jp/qa-competency-support-service/2026-09-02T00:43:46+09:00https://ecompliance.co.jp/quality-assurance-for-device-software/2026-08-31T04:48:01+09:00https://ecompliance.co.jp/about-the-gmp-ordinance-revision/2018-01-13T15:09:00+09:00https://ecompliance.co.jp/senior-management-gmp-responsibility/2026-08-31T04:47:52+09:00https://ecompliance.co.jp/apple-supplier-management/2019-02-18T15:11:00+09:00https://ecompliance.co.jp/how-regulations-should-be/2026-08-31T04:47:58+09:00https://ecompliance.co.jp/490-2/2019-02-13T15:22:44+09:00https://ecompliance.co.jp/process_validation/2019-01-26T15:24:25+09:00https://ecompliance.co.jp/e-records-and-signatures-in-applications/2026-09-02T02:33:30+09:00https://ecompliance.co.jp/ich-q7-api-gmp-guideline/2001-01-13T15:35:00+09:00https://ecompliance.co.jp/ich-q8-pharmaceutical-development/2006-01-13T15:36:00+09:00https://ecompliance.co.jp/ich-q9-quality-risk-management-guideline/2006-09-01T15:37:00+09:00https://ecompliance.co.jp/ich-q10/2010-02-19T15:39:00+09:00https://ecompliance.co.jp/gmp-ordinance-after-law-amendment/2005-03-30T15:40:00+09:00https://ecompliance.co.jp/electronic-trial-records-web-seminar/2026-08-31T04:48:15+09:00https://ecompliance.co.jp/web-seminar-laws-and-ordinances/2026-08-31T04:47:52+09:00https://ecompliance.co.jp/risk-based-monitoring-basics/2013-07-01T15:54:00+09:00https://ecompliance.co.jp/annex-15-qualification-and-validation-j/2019-01-21T13:29:00+09:00https://ecompliance.co.jp/recall-of-drugs-and-devices-2014/2014-11-21T13:31:00+09:00https://ecompliance.co.jp/about-good-distribution-practice/2026-08-31T04:47:59+09:00https://ecompliance.co.jp/the-future-of-japanese-gdp/2026-08-31T04:48:14+09:00https://ecompliance.co.jp/japan-gdp-guideline-2018/2026-08-31T04:47:59+09:00https://ecompliance.co.jp/quality-systems-approach-to-cgmp/2019-01-15T13:35:00+09:00https://ecompliance.co.jp/revised-gmp-draft-comparison-table/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/qulitymanual/2026-09-02T02:07:14+09:00https://ecompliance.co.jp/about-quality-risk/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/quality-risk-management-diagram/2018-12-27T14:01:32+09:00https://ecompliance.co.jp/quality-manual/2018-12-27T14:02:00+09:00https://ecompliance.co.jp/quality-risk-management-procedure/2018-12-27T14:09:00+09:00https://ecompliance.co.jp/management-review-procedure/2018-12-27T14:09:00+09:00https://ecompliance.co.jp/risk-assessment-sheet/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/product-quality-review-examples/2018-12-27T14:11:00+09:00https://ecompliance.co.jp/quality-risk-management-in-pqs/2018-12-27T14:12:00+09:00https://ecompliance.co.jp/excipient-gmp-voluntary-standard-2016/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/site-master-file-apac/2018-12-27T14:15:00+09:00https://ecompliance.co.jp/gmp-enforcement-notice-revision-impact/2026-08-31T04:48:00+09:00https://ecompliance.co.jp/gmp-ordinance-after-pmd-act-amendment/2026-08-31T04:48:00+09:00https://ecompliance.co.jp/validation/2026-08-31T04:47:59+09:00https://ecompliance.co.jp/api-gmp-guideline-and-csv/2026-08-31T04:47:59+09:00https://ecompliance.co.jp/what-is-qualification/2018-12-23T09:57:00+09:00https://ecompliance.co.jp/risk/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/plain/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/riskmanagement_point/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/riskbasedapproach/2019-01-04T10:21:00+09:00https://ecompliance.co.jp/risk_assessment/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/what-is-risk-analysis-ich-q9/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/fmea/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/fta/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/iso-14971-risk-management-standard/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/qrm-5/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/risk-management-procedures-and-forms/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/api-gmp-guideline/2018-12-23T10:42:00+09:00https://ecompliance.co.jp/pharmaceutical-development-guideline/2018-12-23T10:42:00+09:00https://ecompliance.co.jp/pharmaceutical-quality-system-guideline/2018-12-23T10:44:00+09:00https://ecompliance.co.jp/about-data-integrity-2/2026-08-31T04:47:50+09:00https://ecompliance.co.jp/di_misudsnd/2019-03-03T10:54:00+09:00https://ecompliance.co.jp/what-is-falsification/2026-08-31T04:47:49+09:00https://ecompliance.co.jp/alcoa/2026-08-31T04:47:49+09:00https://ecompliance.co.jp/primary-vs-backup-raw-data/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/dynamic-vs-static-electronic-records/2026-08-31T04:47:49+09:00https://ecompliance.co.jp/self-inspection-and-data-integrity/2026-08-31T04:47:49+09:00https://ecompliance.co.jp/mhra-gxp-data-integrity-guidance-2018/2020-02-15T11:05:00+09:00https://ecompliance.co.jp/frequently-asked-questions-compliance/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/what-are-regulatory-requirements/2026-08-31T04:48:03+09:00https://ecompliance.co.jp/computerized-system/2018-06-24T11:38:00+09:00https://ecompliance.co.jp/computerized-system-types/2026-08-31T04:48:03+09:00https://ecompliance.co.jp/four-gmp-software-categories/2019-01-13T11:44:00+09:00https://ecompliance.co.jp/can-gamp-be-used-for-devices/2026-08-31T04:47:49+09:00https://ecompliance.co.jp/csv_qualification_validation/2026-08-31T04:47:38+09:00https://ecompliance.co.jp/the-myth-of-categorization/2026-08-31T04:47:49+09:00https://ecompliance.co.jp/software-categorization/2026-08-31T04:47:58+09:00https://ecompliance.co.jp/processcontrol_csv/2026-08-31T04:48:02+09:00https://ecompliance.co.jp/about-the-csv-guideline/2026-08-31T04:47:59+09:00https://ecompliance.co.jp/annex-11_j/2018-06-24T15:40:00+09:00https://ecompliance.co.jp/vendor-audit-topics/2019-01-22T15:42:00+09:00https://ecompliance.co.jp/csv-guideline-sample/2019-02-26T11:34:00+09:00https://ecompliance.co.jp/publication-seminar-qa-2008/2026-08-31T04:47:53+09:00https://ecompliance.co.jp/mhlw-eres-policy-excerpt/2026-09-02T02:33:31+09:00https://ecompliance.co.jp/mhlw-eres-guideline-sample/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/clinical-trial-part11/2026-09-02T00:25:02+09:00https://ecompliance.co.jp/gamp5-seminar-report-2008/2026-08-31T04:48:21+09:00https://ecompliance.co.jp/outlook-for-part11-revision-2008/2026-08-31T04:48:17+09:00https://ecompliance.co.jp/global-projects-in-pharma-2000/2026-09-02T02:35:13+09:00https://ecompliance.co.jp/publication-seminar-materials-2008/2008-10-07T14:36:00+09:00https://ecompliance.co.jp/j_csv/2026-08-31T04:48:15+09:00https://ecompliance.co.jp/mhlw-computerized-system-guideline-draft/2026-08-31T04:48:16+09:00https://ecompliance.co.jp/mhlw-csv-guideline-review-2008/2026-08-31T04:48:16+09:00https://ecompliance.co.jp/risks-of-digitization/2019-02-12T14:56:00+09:00https://ecompliance.co.jp/understanding-mhlw-ordinance-44/2026-08-31T04:48:20+09:00https://ecompliance.co.jp/eres-guideline-mhlw-document/2026-08-31T04:48:19+09:00https://ecompliance.co.jp/problems-with-excel-records/2026-08-31T04:47:52+09:00https://ecompliance.co.jp/paper-vs-electronic-authority/2019-02-12T15:01:00+09:00https://ecompliance.co.jp/part11-inspection-trends/2019-02-12T15:03:00+09:00https://ecompliance.co.jp/e-records-in-applications-2005/2026-09-02T00:25:03+09:00https://ecompliance.co.jp/public-comment-responses/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/what-is-the-e-document-act/2026-08-31T04:48:20+09:00https://ecompliance.co.jp/eres-guideline-english/2019-02-12T15:13:00+09:00https://ecompliance.co.jp/about-electronic-signatures/2026-08-31T04:48:21+09:00https://ecompliance.co.jp/eres-practice-1-risks-and-requirements/2026-08-31T04:48:18+09:00https://ecompliance.co.jp/eres-practice-2-related-laws/2026-08-31T04:48:18+09:00https://ecompliance.co.jp/eres-practice-3-guideline-review-1/2026-08-31T04:48:18+09:00https://ecompliance.co.jp/eres-practice-4-guideline-review-2/2026-08-31T04:48:18+09:00https://ecompliance.co.jp/eres-practice-5-guideline-review-3/2026-08-31T04:48:18+09:00https://ecompliance.co.jp/eres-practice-6-compliance-challenges/2026-08-31T04:48:18+09:00https://ecompliance.co.jp/eres-course-7-compliance-issues-2/2026-08-31T04:48:17+09:00https://ecompliance.co.jp/eres-practice-8-risk-based-approach/2008-01-25T15:28:00+09:00https://ecompliance.co.jp/eres-practice-9-using-edc-systems/2026-08-31T04:48:17+09:00https://ecompliance.co.jp/eres-practice-10-jpma-edc-guidance-1/2026-08-31T04:48:17+09:00https://ecompliance.co.jp/eres-practice-11-jpma-edc-guidance-2/2026-08-31T04:48:17+09:00https://ecompliance.co.jp/eres-course-12-guideline-inspection-start/2026-08-31T04:48:16+09:00https://ecompliance.co.jp/electronic-signature-act-2000/2026-08-31T04:48:21+09:00https://ecompliance.co.jp/e-document-law-2004/2026-08-31T04:48:20+09:00https://ecompliance.co.jp/mhlw-ordinance-on-electronic-storage/2026-08-31T04:48:19+09:00https://ecompliance.co.jp/eres-policy-procedure-template/2015-01-25T15:40:00+09:00https://ecompliance.co.jp/kaizen/2019-01-04T15:48:00+09:00https://ecompliance.co.jp/why-pharma-lags-in-capa-adoption/2026-08-31T04:47:49+09:00https://ecompliance.co.jp/heinrich/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/preventive-action-is-risk-management/2026-08-31T04:48:14+09:00https://ecompliance.co.jp/writing-capa-procedures-for-fda/2026-08-31T04:48:03+09:00https://ecompliance.co.jp/writing-complaint-handling-procedures/2026-08-31T04:48:00+09:00https://ecompliance.co.jp/edc-management-sheet-review/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/getting-started-with-edc/2026-08-31T04:48:15+09:00https://ecompliance.co.jp/edc-clinical-trial-course-1/2026-08-31T04:48:15+09:00https://ecompliance.co.jp/edc-clinical-trial-course-2/2026-09-02T00:25:03+09:00https://ecompliance.co.jp/edc-clinical-trial-course-3/2026-08-31T04:48:15+09:00https://ecompliance.co.jp/guidance-on-electronic-trial-data/2007-12-26T10:23:00+09:00https://ecompliance.co.jp/csv-guideline-qa/2026-08-31T04:47:49+09:00https://ecompliance.co.jp/public-comment-results/2019-02-26T12:09:00+09:00https://ecompliance.co.jp/draft-csv-guideline/2026-08-31T04:48:02+09:00https://ecompliance.co.jp/toyama-csv-inspection-2012/2019-02-26T12:12:00+09:00https://ecompliance.co.jp/osaka-csv-policy-2012/2019-02-26T12:14:00+09:00https://ecompliance.co.jp/osaka-csv-guidance-notice-2012/2019-02-26T13:19:00+09:00https://ecompliance.co.jp/notice-on-periodic-gmp-inspection/2019-02-26T13:20:00+09:00https://ecompliance.co.jp/qsit-design-control-preparation/2019-02-18T13:35:00+09:00https://ecompliance.co.jp/qsit-management-control-preparation/2019-02-18T13:36:00+09:00https://ecompliance.co.jp/1301-2/2004-06-01T13:29:00+09:00https://ecompliance.co.jp/purpose-of-validation-reports/2004-06-08T14:10:00+09:00https://ecompliance.co.jp/what-is-quality-control/2026-08-31T04:48:20+09:00https://ecompliance.co.jp/what-is-quality-assurance/2026-08-31T04:48:20+09:00https://ecompliance.co.jp/where-is-part11-heading/2026-08-31T04:48:20+09:00https://ecompliance.co.jp/risk-based-approach/2026-08-31T04:48:20+09:00https://ecompliance.co.jp/csv-and-quality-assurance/2026-08-31T04:48:19+09:00https://ecompliance.co.jp/reliability-assurance-in-csv/2026-08-31T04:48:19+09:00https://ecompliance.co.jp/urs-and-pq/2005-06-20T14:35:00+09:00https://ecompliance.co.jp/what-is-authenticity/2006-07-09T14:37:00+09:00https://ecompliance.co.jp/what-is-readability/2006-07-18T14:39:00+09:00https://ecompliance.co.jp/what-is-durability/2006-07-24T14:42:00+09:00https://ecompliance.co.jp/what-is-preservation/2006-08-23T14:44:00+09:00https://ecompliance.co.jp/what-is-an-electronic-signature/2006-11-16T14:50:00+09:00https://ecompliance.co.jp/documents-requiring-e-signature/2007-02-13T14:54:00+09:00https://ecompliance.co.jp/the-challenge-of-preservation/2008-04-25T14:56:00+09:00https://ecompliance.co.jp/gamp-5-review-analysis/2026-08-31T04:48:17+09:00https://ecompliance.co.jp/part-11-revision-outlook/2026-08-31T04:48:17+09:00https://ecompliance.co.jp/annex-11-revision-review/2026-08-31T04:48:16+09:00https://ecompliance.co.jp/regulators-begin-eres-inspections/2008-10-23T15:18:00+09:00https://ecompliance.co.jp/long-term-preservation-of-e-records/2026-08-31T04:48:16+09:00https://ecompliance.co.jp/edc-trial-reliability-checklist/2026-08-31T04:48:16+09:00https://ecompliance.co.jp/gcp-training-2009-report/2026-08-31T04:48:16+09:00https://ecompliance.co.jp/notes-on-electronic-raw-data/2026-08-31T04:48:15+09:00https://ecompliance.co.jp/about-part-11-inspections/2013-11-07T14:59:00+09:00https://ecompliance.co.jp/has-part-11-inspection-ended/2014-03-24T09:35:00+09:00https://ecompliance.co.jp/deadline-to-respond-to-form-483/2015-11-06T09:35:00+09:00https://ecompliance.co.jp/fda-inspections-and-the-15-minute-rule/2015-12-25T09:35:00+09:00https://ecompliance.co.jp/fda-inspection-tips-part2/2016-05-11T09:55:00+09:00https://ecompliance.co.jp/software-categorization-part2/2026-08-31T04:48:14+09:00https://ecompliance.co.jp/about-form-fda-483/2026-09-02T00:43:47+09:00https://ecompliance.co.jp/pa/2026-08-31T04:48:14+09:00https://ecompliance.co.jp/the-typewriter-excuse/2016-10-17T10:37:00+09:00https://ecompliance.co.jp/about-competency/2026-08-31T04:48:14+09:00https://ecompliance.co.jp/qs/2021-06-21T09:18:00+09:00https://ecompliance.co.jp/importance-of-root-cause/2026-08-31T04:48:14+09:00https://ecompliance.co.jp/root-cause-and-capa-importance/2026-08-31T04:48:14+09:00https://ecompliance.co.jp/dataintegrity/2017-05-08T10:48:59+09:00https://ecompliance.co.jp/csv-deliverables-and-control/2026-08-31T04:48:14+09:00https://ecompliance.co.jp/riskbasedapproach-2/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/about-functional-specifications/2026-08-31T04:48:05+09:00https://ecompliance.co.jp/misreading-the-intent-of-validation/2026-08-31T04:48:04+09:00https://ecompliance.co.jp/about-data-analysis/2026-08-31T04:48:04+09:00https://ecompliance.co.jp/dynamic-electronic-data/2017-10-02T11:13:00+09:00https://ecompliance.co.jp/cs_principles/2026-08-31T04:48:04+09:00https://ecompliance.co.jp/closed-vs-open-systems/2026-08-31T04:48:00+09:00https://ecompliance.co.jp/fda_di/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/qrm-2/2026-08-31T04:47:58+09:00https://ecompliance.co.jp/order-of-data-integrity-actions/2026-08-31T04:47:48+09:00https://ecompliance.co.jp/why-retrospective-validation-ended/2026-08-31T04:47:48+09:00https://ecompliance.co.jp/vv/2019-05-09T11:50:00+09:00https://ecompliance.co.jp/misconceptions-about-capa/2019-06-21T11:50:00+09:00https://ecompliance.co.jp/questions-about-csv/2026-08-31T04:47:48+09:00https://ecompliance.co.jp/qrm-4/2026-09-02T02:07:14+09:00https://ecompliance.co.jp/questioning-the-gmp-ordinance-name/2026-08-31T04:47:47+09:00https://ecompliance.co.jp/pqs/2026-08-31T04:47:47+09:00https://ecompliance.co.jp/quality-goals-and-business-goals/2020-03-10T14:19:00+09:00https://ecompliance.co.jp/pandemic-and-bcp/2026-08-31T04:47:46+09:00https://ecompliance.co.jp/self-inspection/2020-03-30T14:19:00+09:00https://ecompliance.co.jp/revised-gmp-approval-compliance/2020-04-01T14:19:00+09:00https://ecompliance.co.jp/iso-9001/2020-04-27T14:19:00+09:00https://ecompliance.co.jp/importance-of-communication/2026-08-31T04:47:40+09:00https://ecompliance.co.jp/electronic_seal/2026-08-31T04:47:40+09:00https://ecompliance.co.jp/logicalthinking/2020-06-02T14:27:00+09:00https://ecompliance.co.jp/revised-pmd-act-effective-date/2026-08-31T04:47:39+09:00https://ecompliance.co.jp/alcoa-and-alcoa-plus/2026-08-31T04:47:39+09:00https://ecompliance.co.jp/calibration-vs-inspection/2026-08-31T04:47:39+09:00https://ecompliance.co.jp/remote-inspection-in-new-normal/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/why-do-we-need-sops/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/draft-compliance-guideline/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/is-data-integrity-important/2020-08-20T14:36:00+09:00https://ecompliance.co.jp/cloud_eres/2020-09-04T14:36:00+09:00https://ecompliance.co.jp/printing-because-not-gxp/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/csvtocsa/2026-08-31T04:47:38+09:00https://ecompliance.co.jp/revised-gmp-comparison-table-download/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/reviewing-the-draft-revised-gmp/2021-01-18T09:35:00+09:00https://ecompliance.co.jp/are-forms-part-of-sops/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/benefits-of-supplier-audits/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/iso-13485-revision-key-points/2026-08-31T04:48:04+09:00https://ecompliance.co.jp/quality-management-system/2018-04-10T09:56:00+09:00https://ecompliance.co.jp/management-responsibility/2018-07-02T09:56:00+09:00https://ecompliance.co.jp/resource-management-part1/2026-08-31T04:48:00+09:00https://ecompliance.co.jp/resource-management-part2/2026-08-31T04:48:00+09:00https://ecompliance.co.jp/revised-qms-ordinance-key-points/2026-08-31T04:48:00+09:00https://ecompliance.co.jp/fda-inspection-outcomes/2018-12-25T09:56:00+09:00https://ecompliance.co.jp/fda-inspections-suspended/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/misunderstanding-design-control/2019-05-31T10:37:00+09:00https://ecompliance.co.jp/capa/2019-06-10T10:37:00+09:00https://ecompliance.co.jp/exclusion-vs-not-applicable/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/safe-design-of-medical-devices/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/design-vs-design-control/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/developing-medical-device-software/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/about-the-iso-14971-revision/2019-11-13T11:10:00+09:00https://ecompliance.co.jp/iso-149712019-1/2019-11-29T11:14:00+09:00https://ecompliance.co.jp/iso-149712019-2/2019-12-09T11:14:00+09:00https://ecompliance.co.jp/fda-14971/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/complicated_qms/2020-02-03T11:14:00+09:00https://ecompliance.co.jp/misuse_useerror-2/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/managing-documents-and-records/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/timing-of-device-clinical-trials/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/vigilance-system-under-mdr/2020-05-18T11:19:00+09:00https://ecompliance.co.jp/usability/2020-06-02T11:29:00+09:00https://ecompliance.co.jp/latest-mdr-schedule/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/about-data-integrity/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/designtransfer/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/about-the-fda-qsr-revision/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/clinical-and-performance-evaluation/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/misuse_useerror/2021-02-16T11:42:00+09:00https://ecompliance.co.jp/is-it-a-medical-device-program/2026-09-02T00:43:46+09:00https://ecompliance.co.jp/what-is-fda-case-for-quality/2021-03-24T17:18:49+09:00https://ecompliance.co.jp/gmp/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/remote-inspection/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/qms/2026-08-31T04:47:38+09:00https://ecompliance.co.jp/fda_remote_inspection/2021-04-15T10:39:00+09:00https://ecompliance.co.jp/importance-of-state-of-the-art/2021-04-05T11:04:00+09:00https://ecompliance.co.jp/backup-vs-archive/2026-08-31T04:47:39+09:00https://ecompliance.co.jp/root-cause-investigation/2022-03-10T11:37:00+09:00https://ecompliance.co.jp/eudamed/2021-05-09T21:20:26+09:00https://ecompliance.co.jp/gmp2021/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/qrm-3/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/mdr-full-implementation/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/new-roles-under-revised-gmp/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/revised-gmp-manufacturing-manager-duties/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/the-day-pharma-stops-selling-drugs/2019-07-25T15:46:00+09:00https://ecompliance.co.jp/software-as-medical-device-guideline/2026-08-31T04:47:38+09:00https://ecompliance.co.jp/gpsv-2/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/qms-2/2026-09-02T00:43:46+09:00https://ecompliance.co.jp/importance-of-clinical-evaluation/2026-08-31T04:47:39+09:00https://ecompliance.co.jp/data-integrity-in-revised-gmp/2026-08-31T04:47:38+09:00https://ecompliance.co.jp/issues-with-revised-gmp/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/ivdr-joint-implementation-plan/2026-08-31T04:47:38+09:00https://ecompliance.co.jp/csa_critical_thinking/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/qualification/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/revised-gmp-data-integrity-officer/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/sops-aligned-with-data-integrity/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/pv_qualification/2021-06-24T09:18:18+09:00https://ecompliance.co.jp/gmp-guide-for-medicinal-products/2021-06-24T09:41:04+09:00https://ecompliance.co.jp/mdcg-2021-13-other-economic-operators/2026-08-31T04:47:37+09:00https://ecompliance.co.jp/calibration/2021-06-30T09:16:08+09:00https://ecompliance.co.jp/japanese-insert-in-us-shipments/2021-06-29T09:28:00+09:00https://ecompliance.co.jp/pic-s-di-guide1/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/hybrid/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/fda-inspection-priorities/2021-07-07T16:01:30+09:00https://ecompliance.co.jp/pharmaceutical-inspection-convention/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/pic-s-di-guide2/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/fda-expectations-on-data-integrity/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/writing-data-integrity-sops/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/part11-inspections-resume/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/data-integrity-and-fraud/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/what-is-qsit-inspection/2021-07-14T16:45:00+09:00https://ecompliance.co.jp/fda-system-inspections/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/from-kaizen-to-capa/2021-07-14T16:48:00+09:00https://ecompliance.co.jp/gmp_toc/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/ichibukaisei/2021-11-17T16:51:00+09:00https://ecompliance.co.jp/gmp-2/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/mdcg-2021-19-udi-in-qms/2021-07-22T08:11:05+09:00https://ecompliance.co.jp/risk_mgt_process/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/gmp_computerrizedsystems/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/goodqualitysw/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/csvtoha/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/computerrizedsystem/2026-09-02T02:11:52+09:00https://ecompliance.co.jp/csv_skill/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/audit_trail/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/shinseisei/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/gmp_summary/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/revised-gmp-primer-video/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/csv-eres-primer-chapter1/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/data-integrity-seminar-1/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/usability-engineering-seminar-1/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/fda-inspection-seminar-video/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/electronic-trial-document-exchange/2021-06-04T12:50:00+09:00https://ecompliance.co.jp/clinical-trials-and-quality-assurance/2021-06-04T12:51:00+09:00https://ecompliance.co.jp/fda-capa-implementation-seminar-1/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/mdr-implementation-seminar-sample/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/revised-gmp-seminar-sample-2/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/mdr-pms-vigilance-seminar-sample/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/revised-gmp-seminar-sample/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/fda-remote-inspection-seminar/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/revised-qms-ordinance-seminar-ch1/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/csa-seminar-sample/2021-04-14T13:51:00+09:00https://ecompliance.co.jp/md_dsgn_sub/2020-12-23T14:00:00+09:00https://ecompliance.co.jp/eres-part11-primer-chapter3/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/eres-part11-primer-video/2020-09-03T14:07:00+09:00https://ecompliance.co.jp/what-is-the-eres-guideline/2014-07-23T14:08:00+09:00https://ecompliance.co.jp/mdcg-2019-5-legacy-device-eudamed/2026-08-31T04:47:37+09:00https://ecompliance.co.jp/udi-regulation-in-europe/2021-08-02T09:27:02+09:00https://ecompliance.co.jp/validation_guide/2021-08-12T10:20:00+09:00https://ecompliance.co.jp/revised-gmp-validation-key-points/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/validation-qualification-definition/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/jgmp_di/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/revised-gmp-capa-key-points/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/jgmp_qrm/2021-08-19T09:16:00+09:00https://ecompliance.co.jp/revised-gmp-and-capa/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/writing-capa-procedures-and-forms/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/qms_yoryo/2021-07-20T11:26:00+09:00https://ecompliance.co.jp/revised-gmp-primer-chapter2/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/csv-eres-primer-chapter9/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/pqs_summary/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/eres-part11-primer-chapter4/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/closed-system-record-requirements/2020-09-03T13:28:00+09:00https://ecompliance.co.jp/e-record-management-requirements/2020-09-03T13:30:00+09:00https://ecompliance.co.jp/qsr-1-document-control/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/qsr-1-fda-enforcement-statistics/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/qsr-2-capa/2020-09-03T13:57:00+09:00https://ecompliance.co.jp/qsr-2-records/2020-09-03T14:00:00+09:00https://ecompliance.co.jp/qsr-2-21cfr820-overview/2020-09-03T14:02:00+09:00https://ecompliance.co.jp/qsr-3-design-input/2020-09-03T14:04:00+09:00https://ecompliance.co.jp/qsr-4-management-process/2020-09-03T14:07:00+09:00https://ecompliance.co.jp/capa_7step/2022-04-13T14:09:00+09:00https://ecompliance.co.jp/qsr-5-resource-process/2020-09-03T14:21:00+09:00https://ecompliance.co.jp/qsr-6-design-verification/2020-09-03T14:22:00+09:00https://ecompliance.co.jp/qsr-6-quality-audit/2020-09-03T14:23:00+09:00https://ecompliance.co.jp/qsr-8-design-transfer/2020-09-03T14:25:00+09:00https://ecompliance.co.jp/qsr-9-design-controls/2021-08-05T14:26:21+09:00https://ecompliance.co.jp/qsr-5-implementing-capa/2020-09-03T14:27:00+09:00https://ecompliance.co.jp/qsr-1-management-control/2020-09-03T14:28:00+09:00https://ecompliance.co.jp/qsr-1-process-control/2020-09-03T14:30:00+09:00https://ecompliance.co.jp/qsr-3-21cfr820-overview/2020-09-03T14:31:00+09:00https://ecompliance.co.jp/qsr-1-building-a-qms/2020-09-03T14:32:00+09:00https://ecompliance.co.jp/qsr-3-qsr-requirements/2020-09-03T14:33:00+09:00https://ecompliance.co.jp/qsr-4-nonconforming-product/2020-09-03T14:34:00+09:00https://ecompliance.co.jp/qsr-2-purchasing-and-identification/2020-09-03T14:37:00+09:00https://ecompliance.co.jp/qsr-2-global-harmonization/2020-09-03T14:38:00+09:00https://ecompliance.co.jp/qsr-6-storage/2020-09-03T14:39:00+09:00https://ecompliance.co.jp/qsr-3-what-is-a-quality-system/2020-09-03T14:42:00+09:00https://ecompliance.co.jp/qsr-1-design-controls-overview/2020-09-03T14:43:00+09:00https://ecompliance.co.jp/qsr-2-fda-inspection-and-capa/2020-09-03T14:44:00+09:00https://ecompliance.co.jp/qsr-2-design-and-development-planning/2020-09-03T14:50:00+09:00https://ecompliance.co.jp/qsr-1-what-is-iso14971/2020-09-03T14:51:00+09:00https://ecompliance.co.jp/qsr-3-risk-management-process/2020-09-03T14:52:00+09:00https://ecompliance.co.jp/qsr-4-design-output/2020-09-03T14:53:00+09:00https://ecompliance.co.jp/qsr-7-distribution/2020-09-03T14:56:00+09:00https://ecompliance.co.jp/qsr-3-receiving/2020-09-03T14:57:00+09:00https://ecompliance.co.jp/qsr-5-packaging-and-labeling/2020-09-03T14:59:00+09:00https://ecompliance.co.jp/qsr-8-installation/2020-09-03T15:00:00+09:00https://ecompliance.co.jp/qsr-9-design-changes/2020-09-03T15:02:00+09:00https://ecompliance.co.jp/qsr-9-servicing/2020-09-03T15:03:00+09:00https://ecompliance.co.jp/qsr-7-design-validation/2020-09-03T15:04:00+09:00https://ecompliance.co.jp/csv-purpose/2021-08-06T09:21:00+09:00https://ecompliance.co.jp/human_error/2026-09-01T19:46:00+09:00https://ecompliance.co.jp/complaint/2021-08-11T09:36:57+09:00https://ecompliance.co.jp/conducting-ioq/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/qsr-1-what-is-capa/2020-09-03T13:53:00+09:00https://ecompliance.co.jp/mdr-seminar-15-conformity-assessment/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/mdr-seminar-full-video/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/iso-13485-2016-seminar-01/2026-09-02T00:43:46+09:00https://ecompliance.co.jp/device-qms-requirements-seminar/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/iec-62304-compliance-lecture1/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/accelerator_break/2021-08-17T11:45:00+09:00https://ecompliance.co.jp/fda-inspection-primer-lecture1/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/risk-management-usability-seminar/2020-04-25T13:28:00+09:00https://ecompliance.co.jp/device-software-regulation/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/device-usability-engineering/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/iso-14971-2019-key-changes/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/iso-149712019/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/quality-system/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/entering-the-medical-device-industry/2019-08-04T14:40:00+09:00https://ecompliance.co.jp/fda-qsr-primer-seminar/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/dtx-design-development-submission/2026-09-02T02:27:15+09:00https://ecompliance.co.jp/batch_release/2026-09-01T19:46:00+09:00https://ecompliance.co.jp/device-regulation-primer-3-quality/2026-08-31T04:47:36+09:00https://ecompliance.co.jp/iryokki-to-kiseiyoken/2026-08-31T04:47:36+09:00https://ecompliance.co.jp/device-regulation-primer-5-effectiveness/2026-09-02T00:43:46+09:00https://ecompliance.co.jp/medical-device-submission-authority-inspection/2026-08-31T04:47:36+09:00https://ecompliance.co.jp/device-regulation-primer-2-device-types/2026-08-31T04:47:36+09:00https://ecompliance.co.jp/medical-device-regulatory-basics-safety/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/fda_inspection_raps/2026-09-01T19:46:00+09:00https://ecompliance.co.jp/cybersecurity1/2021-09-01T15:57:36+09:00https://ecompliance.co.jp/pics-di-guidance-part3/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/what-is-an-fda-untitled-letter/2021-09-06T12:05:00+09:00https://ecompliance.co.jp/mdcg-notified-body-distributor-guidance/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/stateofcontrol/2021-09-10T14:44:00+09:00https://ecompliance.co.jp/labeling-udi-storage-primer/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/production-and-service-primer/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/design-controls-primer/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/purchasing-controls-primer/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/fda-510k/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/what-is-ce-marking/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/limits-of-sterility-testing/2026-09-02T00:43:46+09:00https://ecompliance.co.jp/sterilization-basics/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/key-points-of-sterilization-validation/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/medical-device-cybersecurity-part2/2021-09-15T09:21:00+09:00https://ecompliance.co.jp/remote_inspection/2021-10-04T13:20:00+09:00https://ecompliance.co.jp/validation_manager/2021-10-06T13:40:00+09:00https://ecompliance.co.jp/pics-di-guidance-part4/2026-09-02T02:33:31+09:00https://ecompliance.co.jp/validation_bgn/2021-10-15T15:26:26+09:00https://ecompliance.co.jp/purpose-of-iq/2021-10-22T10:38:00+09:00https://ecompliance.co.jp/purpose-of-oq/2021-10-23T10:40:00+09:00https://ecompliance.co.jp/book-revised-gmp-quality-system/2026-09-02T00:43:46+09:00https://ecompliance.co.jp/purpose-of-pq/2021-10-25T09:34:00+09:00https://ecompliance.co.jp/how_to_part11/2021-11-10T13:56:00+09:00https://ecompliance.co.jp/revised-qms-ordinance-vs-iso13485/2026-09-02T00:43:46+09:00https://ecompliance.co.jp/quality-systems-approach-to-pharmaceutical-cgmp-regulations/2006-09-30T22:18:00+09:00https://ecompliance.co.jp/gdp-for-human-medicinal-products/2026-09-02T02:07:14+09:00https://ecompliance.co.jp/pics-gdp-for-medicinal-products/2022-01-09T21:35:40+09:00https://ecompliance.co.jp/medical-device-cybersecurity-handbook/2026-09-01T19:46:00+09:00https://ecompliance.co.jp/device-cybersecurity-guidance-japan/2026-08-31T04:48:00+09:00https://ecompliance.co.jp/part11_qa/2022-02-08T18:15:47+09:00https://ecompliance.co.jp/fda-to-issue-part11-qa-guidance/2022-02-08T13:46:00+09:00https://ecompliance.co.jp/ichq9-r1/2026-08-31T04:47:35+09:00https://ecompliance.co.jp/horizontal_expansion/2022-05-11T14:02:39+09:00https://ecompliance.co.jp/eudamed-feg/2026-08-31T04:47:35+09:00https://ecompliance.co.jp/how-to-build-a-qms/2022-05-17T16:49:29+09:00https://ecompliance.co.jp/healthcare-cybersecurity-reinforcement/2022-05-17T17:25:30+09:00https://ecompliance.co.jp/legacy-device-cybersecurity-guidance/2022-05-17T17:44:19+09:00https://ecompliance.co.jp/pics-gmp-annex16-established/2022-03-16T13:44:00+09:00https://ecompliance.co.jp/fewer-data-integrity-findings/2022-03-14T16:17:00+09:00https://ecompliance.co.jp/ich-q9-revision-public-comment/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/fda-resumes-domestic-inspections/2022-02-06T13:00:00+09:00https://ecompliance.co.jp/drug-manufacturer-quality-systems/2026-09-02T00:43:46+09:00https://ecompliance.co.jp/three-requirements-of-authenticity/2022-01-25T13:31:00+09:00https://ecompliance.co.jp/regulatory-differences-us-eu-japan/2022-01-23T15:27:00+09:00https://ecompliance.co.jp/importance-of-fast-time-to-market/2022-01-19T15:32:00+09:00https://ecompliance.co.jp/deadline-for-marketing-authorization/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/does-validation-replace-verification/2022-01-20T15:50:00+09:00https://ecompliance.co.jp/is-iso13485-certification-mandatory/2022-01-12T16:10:00+09:00https://ecompliance.co.jp/qcd-in-purchasing-controls/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/design-change-is-not-capa/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/what-is-a-technical-report/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/file/2021-11-26T16:52:00+09:00https://ecompliance.co.jp/device-manufacturing-validation/2021-11-20T18:19:00+09:00https://ecompliance.co.jp/concession-only-once/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/do-not-use-fmea-in-device-design/2021-11-06T11:53:00+09:00https://ecompliance.co.jp/japanese-package-insert-for-us-export/2021-06-29T13:19:00+09:00https://ecompliance.co.jp/misuse-vs-useerror/2026-09-02T02:27:14+09:00https://ecompliance.co.jp/managementreview/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/why-clean-and-dry-before-sterilization/2021-12-21T14:48:00+09:00https://ecompliance.co.jp/does-every-system-need-csv/2021-12-03T15:05:00+09:00https://ecompliance.co.jp/blind-compliance/2021-11-29T15:11:00+09:00https://ecompliance.co.jp/what-is-preventive-action/2022-06-06T14:52:00+09:00https://ecompliance.co.jp/risk_analysis/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/documents-vs-records/2022-06-14T13:16:00+09:00https://ecompliance.co.jp/is-iso13485-certification-required/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/hhs-fda-audit/2022-07-08T13:33:14+09:00https://ecompliance.co.jp/en-iso-14971-2019/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/csv_importance/2022-07-08T09:23:00+09:00https://ecompliance.co.jp/warning-letters-on-csv-part11/2026-09-01T19:46:00+09:00https://ecompliance.co.jp/what-does-good-quality-mean/2022-08-07T10:43:00+09:00https://ecompliance.co.jp/are-fda-inspectors-competent/2022-08-12T10:50:00+09:00https://ecompliance.co.jp/fda-proposes-qsr-revision/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/qmsr-draft/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/quality-culture-data-integrity/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/fda-csa-draft/2026-08-31T04:47:35+09:00https://ecompliance.co.jp/importance-of-competency-matrix/2022-09-05T10:03:00+09:00https://ecompliance.co.jp/fda-csa-draft-2/2026-08-31T04:47:35+09:00https://ecompliance.co.jp/qsr/2022-10-15T09:32:39+09:00https://ecompliance.co.jp/from-qsr-to-qmsr/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/riskmanagement1-1/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/pics-gmp-annex11-revision/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/why-sashimi-tastes-worse-at-home/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/what-are-essential-principles/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/three-principles-of-gmp/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/birth-of-validation-concept/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/process-validation-prerequisites/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/purpose-of-pest-control/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/why-data-integrity-is-hard/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/action-limit-and-alert-level/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/what-is-digital-therapeutics/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/iso-13485-vs-qmsr-draft-gaps/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/di_cont_improve/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/cybersecurity-now-mandatory/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/about-open-systems/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/part11-history-and-trends/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/di-beyond-security-and-audit-trail/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/3step_method/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/good_quality/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/complaint-2/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/good_quality-2/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/good_quality-2-2/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/complaint-2-2/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/complaint-2-2-2/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/3step_method-copy/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/3step_method-2/2023-06-13T14:54:40+09:00https://ecompliance.co.jp/3step_method-2-2/2023-07-26T11:40:08+09:00https://ecompliance.co.jp/non-conforming/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/why-audits-are-necessary/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/risk_analysis-copy/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/managing-the-dhf/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/competency-and-training-needs/2023-08-21T10:47:00+09:00https://ecompliance.co.jp/history-of-fda-device-regulation/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/maintaining-validated-state/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/part11-vs-data-integrity/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/iec-62304/2026-08-31T04:47:34+09:00https://ecompliance.co.jp/what-is-process-validation/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/who-is-the-user-in-csv/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/3step_method-2-2-copy/2023-09-05T11:00:23+09:00https://ecompliance.co.jp/3step_method-2-2-copy-2/2023-09-06T11:15:02+09:00https://ecompliance.co.jp/3step_method-2-copy/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/validation-2/2026-09-02T02:27:13+09:00https://ecompliance.co.jp/fda-dhf/2023-09-25T10:00:00+09:00https://ecompliance.co.jp/human_error-2/2023-09-29T07:40:00+09:00https://ecompliance.co.jp/state-of-the-art/2023-10-30T15:32:00+09:00https://ecompliance.co.jp/correcting-raw-data/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/usability-engineering-scope/2024-01-23T13:12:29+09:00https://ecompliance.co.jp/boiled-frog-syndrome/2024-01-29T12:53:54+09:00https://ecompliance.co.jp/fda-issues-qmsr/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/fda/2024-03-11T09:29:10+09:00https://ecompliance.co.jp/mdrx/2026-08-31T04:47:34+09:00https://ecompliance.co.jp/cyber-security/2026-09-02T02:35:13+09:00https://ecompliance.co.jp/di_cont_improve-copy/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/fda20240919/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/fda-electronic-systems-guidance/2026-08-31T04:47:34+09:00https://ecompliance.co.jp/fda20241004/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/gmp20241009/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/mdr_20241016/2024-10-16T11:20:38+09:00https://ecompliance.co.jp/gmp_20241029/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/ai_20241031/2024-10-31T10:59:27+09:00https://ecompliance.co.jp/rwd_20241101/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/usp_20241104/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/shortage-of-supply_202411-05/2024-11-05T23:19:26+09:00https://ecompliance.co.jp/di_20241107/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/dtx_20241112/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/di_20241115/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/raw-data_20241118/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/separation_20241122/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/clinical-evaluation_20241123/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/quality-culture_20241126/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/complaint-management_20241127/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/lot_20241128/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/internal-audit_20241129/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/electronic-raw-data_20241205/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/use-error_20241204/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/gamp_20241205/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/basic-requirements-standards_20241206/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/qsr_20241210/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/data_20241212/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/usability_20241213/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/di_20241218/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/csv_20241225/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/di_20241227/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/sted_20241220/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/di_20250106/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/attached-file_20241226/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/di_20250117/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/csv_20250121/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/evaluation_20250107/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/iec-81001-5-1_20250120/2026-09-02T02:33:31+09:00https://ecompliance.co.jp/audit-trail_20250123/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/r-map_20250127/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/license_20250128/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/di_20250201/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/usability-engineering_20250130/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/fda_20250203/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/alcoa_20250205/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/di_20250207/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/infusion-pump_20250204/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/aed_20250206/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/di_20250212/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/electrocardiogram_20250213/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/qrm_20250218/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/qsr_20250215/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/fmea-rpn_20250219/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/iec-81001-5-1-2021_20250220/2026-09-02T02:33:31+09:00https://ecompliance.co.jp/qrm_20250304/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/gmp_20250306/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/dkat_20250310/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/compliance_20250312/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/dmf_20250314/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/batch-record_20250317/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/bioburden_20250319/2026-08-31T04:47:28+09:00https://ecompliance.co.jp/hepa_20250321/2026-08-31T04:47:28+09:00https://ecompliance.co.jp/biofilm_20250324/2026-08-31T04:47:27+09:00https://ecompliance.co.jp/particle-counting_20250326/2026-08-31T04:47:27+09:00https://ecompliance.co.jp/eir_20250327/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/eir_20250331/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/international-standards_20250221/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/jis_20250305/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/en_20250311/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/evaluation_20250313/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/er_20250318/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/sted_20250320/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/application-and-reimbursement-strategies_20250325/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/anvisa_20250328/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/health-canada_20250401/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/heparin_20250402/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/fda_20250404/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/fda_20250407/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/fda_20250409/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/gmp_20250410/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/fda_20250414/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/self-inspection_20250415/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/korea_20250403/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/australia_20250408/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/fda_20250411/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/auditor_20250417/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/quality_20250421/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/quality_20250422/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/quality_20250424/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/rmf/2026-08-31T04:47:17+09:00https://ecompliance.co.jp/risk_20250416/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/design-management_20250418/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/design-verification_20250423/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/quality-policy-and-quality-goals_20250430/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/pmda_20250507/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/pmda_20250509/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/dice_20250514/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/qc_20250425/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/csa-guide/2026-09-02T22:00:24+09:00https://ecompliance.co.jp/sop_20250428/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/4m_20250516/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/qa_20250501/2026-08-31T04:47:25+09:00https://ecompliance.co.jp/4m3h/2026-08-31T04:47:02+09:00https://ecompliance.co.jp/counterfeit-medicine_20250502/2026-08-31T04:47:25+09:00https://ecompliance.co.jp/batch-record_20250508/2026-08-31T04:47:24+09:00https://ecompliance.co.jp/capa_20250512/2026-08-31T04:47:24+09:00https://ecompliance.co.jp/fda_20250513/2026-08-31T04:47:24+09:00https://ecompliance.co.jp/fda_20250521/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/20114-2/2026-09-02T00:43:45+09:00https://ecompliance.co.jp/fda_20250515/2026-08-31T04:47:24+09:00https://ecompliance.co.jp/labeling_20250523/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/capa_20250528/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/software_20250604/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/risk_20250606/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/safety_20250610/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/3-step-method_20250611/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/harm_20250613/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/fda_20250519/2026-08-31T04:47:24+09:00https://ecompliance.co.jp/gmp_20250520/2026-08-31T04:47:23+09:00https://ecompliance.co.jp/correction-vs-capa/2026-08-31T04:47:23+09:00https://ecompliance.co.jp/preventive-measure_20250526/2026-08-31T04:47:23+09:00https://ecompliance.co.jp/fda_20250527/2026-08-31T04:47:23+09:00https://ecompliance.co.jp/pharmaceutical-device-law_20250529/2026-08-31T04:47:23+09:00https://ecompliance.co.jp/fast-time-to-market_20250530/2026-08-31T04:47:23+09:00https://ecompliance.co.jp/drug-price_20250602/2026-08-31T04:47:22+09:00https://ecompliance.co.jp/quality-culture_20250603/2026-09-02T00:43:45+09:00https://ecompliance.co.jp/validation_20250605/2026-08-31T04:47:22+09:00https://ecompliance.co.jp/gamp_20250609/2026-08-31T04:47:22+09:00https://ecompliance.co.jp/risk-based-approach_20250612/2026-08-31T04:47:18+09:00https://ecompliance.co.jp/computerized-system_20250616/2026-08-31T04:47:18+09:00https://ecompliance.co.jp/why-software-category-classification/2026-09-02T00:43:45+09:00https://ecompliance.co.jp/misuse_20250618/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/samd_20250620/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/iec62304_20250625/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/v-model_20250619/2026-08-31T04:47:18+09:00https://ecompliance.co.jp/traceability-matrix_20250623/2026-08-31T04:47:17+09:00https://ecompliance.co.jp/data-integrity_20250624/2026-08-31T04:47:17+09:00https://ecompliance.co.jp/fda_20250626/2026-08-31T04:47:17+09:00https://ecompliance.co.jp/critical-thinking_20250630/2026-08-31T04:47:17+09:00https://ecompliance.co.jp/dq-iq-oq-pq-explained/2026-08-31T04:47:17+09:00https://ecompliance.co.jp/csa_20250703/2026-08-31T04:47:16+09:00https://ecompliance.co.jp/benefit-risk-assessment-_20250627/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/medical-device-family-_202500702/2026-09-02T02:27:12+09:00https://ecompliance.co.jp/supplier_20250707/2026-08-31T04:47:16+09:00https://ecompliance.co.jp/fda_20250708/2026-08-31T04:47:16+09:00https://ecompliance.co.jp/gmp_20250710/2026-08-31T04:47:16+09:00https://ecompliance.co.jp/risk-assessment_20250714/2026-08-31T04:47:16+09:00https://ecompliance.co.jp/part11_20250715/2026-08-31T04:47:16+09:00https://ecompliance.co.jp/script_20250717/2026-08-31T04:47:15+09:00https://ecompliance.co.jp/risk-management-_202500709/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/form-483-and-warning-letter_20250722/2026-08-31T04:47:15+09:00https://ecompliance.co.jp/compliance-program_20250724/2026-08-31T04:47:15+09:00https://ecompliance.co.jp/ssm_20250728/2026-08-31T04:47:15+09:00https://ecompliance.co.jp/pai_20250729/2026-08-31T04:47:15+09:00https://ecompliance.co.jp/fda_20250731/2026-08-31T04:47:14+09:00https://ecompliance.co.jp/qsit_20250804/2026-09-02T02:35:12+09:00https://ecompliance.co.jp/fda_20250805/2026-08-31T04:47:14+09:00https://ecompliance.co.jp/smf_20250807/2026-08-31T04:47:14+09:00https://ecompliance.co.jp/capa_20250812/2026-08-31T04:47:14+09:00https://ecompliance.co.jp/di_20250814/2026-08-31T04:47:13+09:00https://ecompliance.co.jp/corrections-and-corrective-actions_20250818/2026-08-31T04:47:13+09:00https://ecompliance.co.jp/root-cause_20250819/2026-08-31T04:47:13+09:00https://ecompliance.co.jp/self-inspection_20250821/2026-08-31T04:47:13+09:00https://ecompliance.co.jp/pdca_20250825/2026-08-31T04:47:13+09:00https://ecompliance.co.jp/ich-q10_20250826/2026-08-31T04:47:13+09:00https://ecompliance.co.jp/qmqaqc_20250828/2026-08-31T04:47:12+09:00https://ecompliance.co.jp/ai_20250901/2026-08-31T04:47:12+09:00https://ecompliance.co.jp/sop_20250902/2026-08-31T04:47:12+09:00https://ecompliance.co.jp/inspection_20250904/2026-08-31T04:47:11+09:00https://ecompliance.co.jp/ai_20250908/2026-08-31T04:47:08+09:00https://ecompliance.co.jp/eir_20250909/2026-08-31T04:47:08+09:00https://ecompliance.co.jp/inspection_20250911/2026-08-31T04:47:07+09:00https://ecompliance.co.jp/ai_20250916/2026-08-31T04:47:07+09:00https://ecompliance.co.jp/form-484_20250918/2026-08-31T04:47:07+09:00https://ecompliance.co.jp/ai_20250922/2026-08-31T04:47:07+09:00https://ecompliance.co.jp/affidavit_20250925/2026-08-31T04:47:06+09:00https://ecompliance.co.jp/csa_20250929/2026-08-31T04:47:06+09:00https://ecompliance.co.jp/fda_20251002/2026-08-31T04:47:06+09:00https://ecompliance.co.jp/ai_20251006/2026-08-31T04:47:06+09:00https://ecompliance.co.jp/fda_20251007/2026-08-31T04:47:06+09:00https://ecompliance.co.jp/qms_20251009/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/ai_20251014/2026-08-31T04:47:05+09:00https://ecompliance.co.jp/fda_20251016/2026-08-31T04:47:05+09:00https://ecompliance.co.jp/ai_20251020/2026-08-31T04:47:05+09:00https://ecompliance.co.jp/form-484_20251021/2026-08-31T04:47:05+09:00https://ecompliance.co.jp/inspection_20251023/2026-08-31T04:47:05+09:00https://ecompliance.co.jp/ai_20251027/2026-08-31T04:47:04+09:00https://ecompliance.co.jp/inspection_20251028/2026-08-31T04:47:04+09:00https://ecompliance.co.jp/di_20251030/2026-08-31T04:47:04+09:00https://ecompliance.co.jp/ai_20251104/2026-08-31T04:47:04+09:00https://ecompliance.co.jp/fda_20251106/2026-08-31T04:47:03+09:00https://ecompliance.co.jp/it_20251110/2026-08-31T04:47:03+09:00https://ecompliance.co.jp/electronic-records_20251111/2026-08-31T04:47:03+09:00https://ecompliance.co.jp/record_20251113/2026-08-31T04:47:03+09:00https://ecompliance.co.jp/ai_20251117/2026-08-31T04:47:03+09:00https://ecompliance.co.jp/electronic-records_20251118/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/imposter_20251120/2025-11-20T12:32:24+09:00https://ecompliance.co.jp/security_20251125/2026-08-31T04:47:02+09:00https://ecompliance.co.jp/eu-gmp-annex-22_20251127/2026-08-31T04:47:02+09:00https://ecompliance.co.jp/ai_20251201/2026-08-31T04:47:01+09:00https://ecompliance.co.jp/er-es_20251204/2026-08-31T04:47:01+09:00https://ecompliance.co.jp/llm_20251208/2026-08-31T04:47:01+09:00https://ecompliance.co.jp/security_20251209/2026-08-31T04:46:56+09:00https://ecompliance.co.jp/audit-trail_20251211/2026-08-31T04:46:56+09:00https://ecompliance.co.jp/transformer_20251215/2025-12-15T11:50:40+09:00https://ecompliance.co.jp/audit-trail_20251216/2026-08-31T04:46:56+09:00https://ecompliance.co.jp/backup_20251218/2026-08-31T04:46:56+09:00https://ecompliance.co.jp/ai_20251222/2026-08-31T04:46:55+09:00https://ecompliance.co.jp/audit-trail_20251223/2026-08-31T04:46:55+09:00https://ecompliance.co.jp/what-is-federal-register/2026-09-02T00:43:45+09:00https://ecompliance.co.jp/ai_20260105/2026-08-31T04:46:55+09:00https://ecompliance.co.jp/what-is-cfr-title-21/2026-09-02T00:43:45+09:00https://ecompliance.co.jp/part11-origins-history/2026-09-02T00:43:45+09:00https://ecompliance.co.jp/ai_20260113/2026-09-02T00:43:45+09:00https://ecompliance.co.jp/part11-four-unsolved-problems/2026-09-02T00:43:45+09:00https://ecompliance.co.jp/ai-lacks-emotion-imagination/2026-09-02T00:43:45+09:00https://ecompliance.co.jp/what-is-typewriter-excuse/2026-09-02T00:43:45+09:00https://ecompliance.co.jp/why-printouts-unreliable/2026-09-02T00:43:45+09:00https://ecompliance.co.jp/ai-knowledge-limits-company-data/2026-09-02T00:43:44+09:00https://ecompliance.co.jp/what-is-hybrid-system/2026-01-27T22:54:06+09:00https://ecompliance.co.jp/paper-or-electronic-original/2026-09-02T00:43:44+09:00https://ecompliance.co.jp/ivd-_202500711/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/use-error-and-misuse-_202500716/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/fmea-_202500718/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/usability-engineering-_202500723/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/software-item-_202500725/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/software_202500730/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/soup_202500801/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/clean-room_202500806/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/software_202500808/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/software_202500813/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/v-model_202500815/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/software_202500820/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/dtx_202500822/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/software_202500827/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/inspection-review_202500829/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/state-of-the-art_202500903/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/risk_202500905/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/rmf_202500910/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/error_202500912/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/error_202500917/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/usability_202500919/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/use_202500924/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/formative-evaluation-and-summative-evaluation_20251001/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/task-analysis_20251003/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/risk-management_20251008/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/tailoring_20251010/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/uoup_20251015/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/iec62366_20251017/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/international-standards_20251022/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/fda_20251024/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/pre-submission_20251029/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/usability-engineering_20251031/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/usability-engineering_20251105/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/usability_20251107/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/uef_20251112/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/usability_20251114/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/competence_20251119/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/3-step-method_20251121/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/user-profile_20251126/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/usage-environment_20251128/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/advance-product_20251203/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/training_20251205/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/objective-evidence_20251210/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/usability_20251212/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/risk_20251217/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/design-philosophy_20251219/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/usability_20251224/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/regulatory-approach_20251226/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/dtx_20260107/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/pmda_20260109/2026-09-02T02:27:11+09:00https://ecompliance.co.jp/usability-engineering_20260114/2026-08-31T04:46:55+09:00https://ecompliance.co.jp/why-ce-marking-required-devices/2026-09-02T00:43:45+09:00https://ecompliance.co.jp/design-control-vs-design-development/2026-09-02T00:43:44+09:00https://ecompliance.co.jp/why-design-history-file-needed/2026-09-02T00:43:44+09:00https://ecompliance.co.jp/what-is-udi-device-identifier/2026-09-02T00:43:44+09:00https://ecompliance.co.jp/beyond-qsit-fda-device-inspection/2026-09-02T00:43:44+09:00https://ecompliance.co.jp/qc-and-qa_20260206/2026-08-31T04:46:54+09:00https://ecompliance.co.jp/risk-based-approach_20260213/2026-08-31T04:46:54+09:00https://ecompliance.co.jp/labeling_20260218/2026-08-31T04:46:54+09:00https://ecompliance.co.jp/hallucination-improvement-progress/2026-09-02T00:43:44+09:00https://ecompliance.co.jp/excel-ten-problems/2026-09-02T00:25:00+09:00https://ecompliance.co.jp/excel-control-points-gxp/2026-09-02T00:43:44+09:00https://ecompliance.co.jp/ai_20260209/2026-08-31T04:46:54+09:00https://ecompliance.co.jp/electronic-records-long-term-retention/2026-09-02T02:31:15+09:00https://ecompliance.co.jp/what-is-time-capsule-approach/2026-02-12T09:53:03+09:00https://ecompliance.co.jp/gpt-next-token-prediction/2026-08-31T04:46:54+09:00https://ecompliance.co.jp/what-is-migration-approach/2026-08-31T04:46:54+09:00https://ecompliance.co.jp/what-is-legacy-system/2026-08-31T04:46:54+09:00https://ecompliance.co.jp/ai_20260224/2026-08-31T04:46:54+09:00https://ecompliance.co.jp/ai_20260226/2026-08-31T04:46:54+09:00https://ecompliance.co.jp/ai_20260302/2026-08-31T04:46:53+09:00https://ecompliance.co.jp/compliance-policy-guide-7153-17/2026-08-31T04:46:53+09:00https://ecompliance.co.jp/able-laboratories-data-integrity-case/2026-08-31T04:46:53+09:00https://ecompliance.co.jp/ai_20260309/2026-09-01T20:03:25+09:00https://ecompliance.co.jp/qc_20260310/2026-08-31T04:46:53+09:00https://ecompliance.co.jp/compliance_20260312/2026-09-01T20:03:25+09:00https://ecompliance.co.jp/ai_20260316/2026-08-31T04:46:53+09:00https://ecompliance.co.jp/fda_20260317/2026-08-31T04:46:53+09:00https://ecompliance.co.jp/risk-based-approach_20260319/2026-08-31T04:46:53+09:00https://ecompliance.co.jp/ai_20260323/2026-08-31T04:46:53+09:00https://ecompliance.co.jp/predicate-rule_20260326/2026-08-31T04:46:52+09:00https://ecompliance.co.jp/ai_20260330/2026-08-31T04:46:52+09:00https://ecompliance.co.jp/di_20260331/2026-08-31T04:46:52+09:00https://ecompliance.co.jp/part11_20260402/2026-08-31T04:46:52+09:00https://ecompliance.co.jp/chatgpt_20260406/2026-09-01T20:03:25+09:00https://ecompliance.co.jp/21-cfr-part11_20260407/2026-08-31T04:46:52+09:00https://ecompliance.co.jp/validation_20260409/2026-09-02T00:43:44+09:00https://ecompliance.co.jp/ai_20260413/2026-09-02T02:30:08+09:00https://ecompliance.co.jp/21-cfr-part-11_20260414/2026-09-02T00:43:44+09:00https://ecompliance.co.jp/biometrics_20260416/2026-09-02T00:43:44+09:00https://ecompliance.co.jp/ai_20260420/2026-04-20T08:33:38+09:00https://ecompliance.co.jp/three-elements-of-e-signature/2026-09-02T02:30:08+09:00https://ecompliance.co.jp/why-part11-requires-two-factors/2026-09-02T02:30:08+09:00https://ecompliance.co.jp/bcp-third-form-ai-outage/2026-08-31T04:46:51+09:00https://ecompliance.co.jp/what-is-terminal-check/2026-09-02T00:43:44+09:00https://ecompliance.co.jp/ai-iq-136-who-is-caged/2026-08-31T04:46:47+09:00https://ecompliance.co.jp/ai-wins-with-training-data/2026-08-31T04:46:47+09:00https://ecompliance.co.jp/eighty-percent-of-di-threats/2026-09-02T00:43:44+09:00https://ecompliance.co.jp/falsification-includes-negligence/2026-08-31T04:46:47+09:00https://ecompliance.co.jp/fda-cp-7382-850-qsit-qmsr/2026-09-02T22:00:24+09:00https://ecompliance.co.jp/iryokiki-qms-towa/2026-08-31T04:46:46+09:00https://ecompliance.co.jp/hinshitsu-manual/2026-08-31T04:37:53+09:00https://ecompliance.co.jp/bunsho-kanri/2026-08-31T04:37:51+09:00https://ecompliance.co.jp/kiroku-kanri/2026-08-31T04:37:48+09:00https://ecompliance.co.jp/management-review/2026-08-31T04:37:46+09:00https://ecompliance.co.jp/kyoiku-kunren/2026-08-31T04:37:44+09:00https://ecompliance.co.jp/kaishu/2026-08-31T04:37:58+09:00https://ecompliance.co.jp/quality-rests-on-one-person/2026-08-31T04:46:46+09:00https://ecompliance.co.jp/tools-and-skill-gap/2026-08-31T04:46:46+09:00https://ecompliance.co.jp/unscripted-testing/2026-08-31T04:46:46+09:00https://ecompliance.co.jp/csa-six-steps/2026-08-31T04:46:46+09:00https://ecompliance.co.jp/generative-ai-nuclear-weapon/2026-08-31T04:46:46+09:00https://ecompliance.co.jp/why-experts-err/2026-08-31T04:46:46+09:00https://ecompliance.co.jp/approver-must-not-review/2026-08-31T04:46:46+09:00https://ecompliance.co.jp/csv-delayed-pharma/2026-08-31T04:46:46+09:00https://ecompliance.co.jp/compliance-cost-drug-prices/2026-08-31T04:46:45+09:00https://ecompliance.co.jp/validation-to-assurance/2026-08-31T04:46:45+09:00https://ecompliance.co.jp/samsung-leaked-minutes/2026-08-31T04:46:45+09:00https://ecompliance.co.jp/road-to-csa-guidance/2026-09-01T20:02:13+09:00https://ecompliance.co.jp/electronic-records-beat-paper/2026-09-01T20:02:13+09:00https://ecompliance.co.jp/ai-copilot-you-captain/2026-08-31T04:46:45+09:00https://ecompliance.co.jp/what-is-metadata-data-integrity/2026-09-02T00:43:43+09:00https://ecompliance.co.jp/capa-root-cause-training/2026-08-31T04:46:45+09:00https://ecompliance.co.jp/policy-divergence/2026-08-31T04:46:45+09:00https://ecompliance.co.jp/inspectors-lack-industry/2026-08-31T04:46:45+09:00https://ecompliance.co.jp/case-for-quality-barriers/2026-08-31T04:46:44+09:00https://ecompliance.co.jp/zero-complaints-is-a-lie/2026-08-31T04:46:44+09:00https://ecompliance.co.jp/high-risk-dichotomy/2026-09-01T20:01:37+09:00https://ecompliance.co.jp/graphs-are-not-analysis/2026-08-31T04:46:44+09:00https://ecompliance.co.jp/quality-manual-is-managements/2026-08-31T04:46:44+09:00https://ecompliance.co.jp/praise-failure-reports/2026-08-31T04:46:44+09:00https://ecompliance.co.jp/overestimating-risk-harms/2026-08-31T04:46:44+09:00https://ecompliance.co.jp/gather-not-train-talent/2026-09-02T00:43:43+09:00https://ecompliance.co.jp/misreading-quality-culture/2026-08-31T04:46:44+09:00https://ecompliance.co.jp/empty-training-promises/2026-08-31T04:46:44+09:00https://ecompliance.co.jp/do-not-audit-bad-companies/2026-08-31T04:36:27+09:00https://ecompliance.co.jp/audit-needs-outside-experience/2026-08-31T04:46:44+09:00https://ecompliance.co.jp/data-integrity-three-assurance-elements/2026-09-02T00:43:43+09:00https://ecompliance.co.jp/saas-stock-crash/2026-08-31T04:46:43+09:00https://ecompliance.co.jp/paper-vs-electronic-records/2026-08-31T04:46:43+09:00https://ecompliance.co.jp/what-is-intended-change/2026-09-01T20:01:12+09:00https://ecompliance.co.jp/how-ai-talks-to-ai/2026-08-31T04:46:39+09:00https://ecompliance.co.jp/defining-falsification/2026-09-01T20:01:12+09:00https://ecompliance.co.jp/ai-beats-humans-go-shogi/2026-08-31T04:46:39+09:00https://ecompliance.co.jp/who-goes-in-the-cage/2026-08-31T04:46:39+09:00https://ecompliance.co.jp/bcp-third-scenario/2026-08-31T04:46:38+09:00https://ecompliance.co.jp/part11-collusion-requirement/2026-09-02T02:35:12+09:00https://ecompliance.co.jp/electronic-signature-manifestations/2026-08-31T04:35:55+09:00https://ecompliance.co.jp/audit-is-not-error-hunting/2026-09-02T00:24:59+09:00https://ecompliance.co.jp/reprocessed-device-cleaning/2026-09-02T00:43:43+09:00https://ecompliance.co.jp/astm-f3127-cleaning/2026-09-02T00:43:43+09:00https://ecompliance.co.jp/cleaning-validation-iso13485/2026-09-02T00:43:43+09:00https://ecompliance.co.jp/d-value-and-sal/2026-09-02T00:43:43+09:00https://ecompliance.co.jp/bioburden-and-sterilization/2026-09-02T00:24:59+09:00https://ecompliance.co.jp/endoscope-cleaning-infection/2026-09-02T00:24:59+09:00https://ecompliance.co.jp/validation-vs-verification/2026-08-31T04:46:37+09:00https://ecompliance.co.jp/validation-history-1970s/2026-08-31T04:46:37+09:00https://ecompliance.co.jp/design-transfer-scope/2026-09-01T19:59:21+09:00https://ecompliance.co.jp/design-review-vs-verification/2026-09-02T00:43:43+09:00https://ecompliance.co.jp/what-is-dhf/2026-09-01T19:58:53+09:00https://ecompliance.co.jp/training-three-essentials/2026-09-01T19:58:53+09:00https://ecompliance.co.jp/competency-beyond-skills/2026-09-01T19:58:53+09:00https://ecompliance.co.jp/education-vs-training/2026-09-01T19:58:53+09:00https://ecompliance.co.jp/claude-mythos-27-year-old-bug/2026-09-02T02:30:08+09:00https://ecompliance.co.jp/quitgpt-ai-vendor-risk/2026-09-01T19:58:21+09:00https://ecompliance.co.jp/qmsr-pre-effective-records-inspection/2026-09-02T01:58:06+09:00https://ecompliance.co.jp/qms-integrity-management-review/2026-09-01T19:57:49+09:00https://ecompliance.co.jp/quality-vs-business-goals/2026-09-02T00:43:43+09:00https://ecompliance.co.jp/top-down-quality-management/2026-09-02T00:43:43+09:00https://ecompliance.co.jp/iso13485-exclusion-vs-non-application/2026-09-02T00:43:43+09:00https://ecompliance.co.jp/mdsap-medical-device-single-audit/2026-09-01T19:46:48+09:00https://ecompliance.co.jp/sample-post4/2026-08-31T04:48:04+09:00https://ecompliance.co.jp/sample-post1/2026-09-02T00:43:47+09:00https://ecompliance.co.jp/hello-world/2019-01-04T12:47:00+09:00https://ecompliance.co.jp/sample-post3/2026-08-31T04:47:57+09:00https://ecompliance.co.jp/rxvsmd/2019-02-18T21:50:02+09:00